Counterpoint Global
North America, New York, United States, New York
Description
Counterpoint Global is a fundamental equities team at Morgan Stanley focused on long-term investing.
Investor Profile
Counterpoint Global has made 27 investments, with 2 in the past 12 months and 11% as lead.
Stage Focus
- Post Ipo Equity (33%)
- Series C (19%)
- Series D (19%)
- Series F (7%)
- Series E (7%)
- Series I (4%)
- Series G (4%)
- Series H (4%)
- Series Unknown (4%)
Country Focus
- United States (85%)
- Singapore (4%)
- United Kingdom (4%)
- Canada (4%)
- Israel (4%)
Industry Focus
- Software
- Biotechnology
- Artificial Intelligence (Ai)
- Health Diagnostics
- Analytics
- Machine Learning
- Predictive Analytics
- Information Technology
- Health Care
- Digital Media
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.